Ageing, immunity and influenza: A role for probiotics?

Proceedings of the Nutrition Society

Volumn 73, Issue 2, 2014, Pages 309-317

  Yaqoob, Parveen ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Ageing; Immunity; Influenza; Probiotics

Indexed keywords

INFLUENZA VACCINE; PREBIOTIC AGENT; PROBIOTIC AGENT;

AGING; CAUSE OF DEATH; CONFERENCE PAPER; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; INCIDENCE; INFECTION PREVENTION; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VACCINATION; INTESTINE FLORA; RESPIRATORY TRACT INFECTION; GASTROINTESTINAL TRACT; IMMUNOLOGY; INFLUENZA, HUMAN; MICROBIOLOGY; VACCINATION;

AGING; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY; INFLUENZA, HUMAN; PROBIOTICS; VACCINATION;

EID: 84898596676     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665113003777     Document Type: Conference Paper

References (81)

1. Claesson MJ, Jeffery IB, Conde S, et al. (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184
2. Biagi E, Candela M, Turroni S, et al. (2013) Ageing and gut microbes: Perspectives for health maintenance and longevity. Pharmacol Res 69, 11-20
3. Tiihonen K, Ouwehand AC & Rautonen N (2010) Human intestinal microbiota and healthy ageing. Ageing Res Rev 9, 107-116
4. Mueller S, Saunier K, Hanisch C, et al. (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: A cross-sectional study. Appl Environ Microbiol 72, 1027-1033
5. Mariat D, Firmesse O, Levenez F, et al. (2009) The Firmicutes/ Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9, 123
6. Rajilic-Stojanovic M, Heilig HG, Molenaar D, et al. (2009) Development and application of the human intestinal tract chip, a phylogenetic microarray: Analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 11, 1736-1751
7. Biagi E, Nylund L, Candela M, et al. (2010) Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians. Plos ONE 5, e10667
8. Rupnik M, Wilcox MH & Gerding DN (2009) Clostridium difficile infection: New developments in epidemiology and pathogenesis. Nat Rev Microbiol 7, 526-536
9. Rea MC, O'Sullivan O, Shanahan F, et al. (2012) Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol 50, 867-875
10. Schiffrin EJ, Morley JE, Donnet-Hughes A, et al. (2010) The inflammatory status of the elderly: The intestinal contribution. Mutat Res 690, 50-56
11. Barcenilla A, Pryde SE, Martin JC, et al. (2000) Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 66, 1654-1661
12. Louis P & Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294, 1-8
13. Macia L, Thorburn AN, Binge LC, et al. (2012) Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev 245, 164-176
14. Vallejo AN (2007) Immune remodeling: Lessons from repertoire alterations during chronological aging and in immune-mediated disease. Trends Mol Med 13, 94-102
15. Effros RB (2007) Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 25, 599-604
16. Kovaiou RD, Herndler-Brandstetter D & Grubeck-Loebenstein B (2007) Age-related changes in immunity: Implications for vaccination in the elderly. Expert Rev Mol Med 9, 1-17
17. Yager EJ, Ahmed M, Lanzer K, et al. (2008) Age-Associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med 205, 711-723
18. McElhaney JE (2005) The unmet need in the elderly: Designing new influenza vaccines for older adults. Vaccine 23, Suppl. 1, S10-S25
19. Aspinall R, Del Giudice G, Effros RB, et al. (2007) Challenges for vaccination in the elderly. Immun Ageing 4, 9
20. Calder PC, Ahluwalia N, Albers R, et al. (2013) A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br J Nutr 109, Suppl. 1, S1-34
21. McElhaney JE, Zhou X, Talbot HK, et al. (2012) The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 30, 2060-2067
22. Gavazzi G & Krause KH (2002) Ageing and infection. Lancet Infect Dis 2, 659-666
23. Goodwin K, Viboud C & Simonsen L (2006) Antibody response to influenza vaccination in the elderly: A quantitative review. Vaccine 24, 1159-1169
24. Goronzy JJ, Fulbright JW, Crowson CS, et al. (2001) Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75, 12182-12187
25. Saurwein-Teissl M, Lung TL, Marx F, et al. (2002) Lack of antibody production following immunization in old age: Association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168, 5893-5899
26. McElhaney JE, Xie D, Hager WD, et al. (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176, 6333-6339
27. Food and Agriculture Organization of the United Nations and World Health Organization (2002) Guidelines for the evaluation of probiotics in food. In Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of probiotics in Food [FAO/WHO, editor]. London, Ontario
28. Roberfroid M (2007) Prebiotics: The concept revisited. J Nutr 137, 830S-837S.
29. Ritchie ML & Romanuk TN (2012) A meta-Analysis of probiotic efficacy for gastrointestinal diseases. Plos ONE 7, e34938
30. Pae M, Meydani SN & Wu D (2012) The role of nutrition in enhancing immunity in aging. Aging Dis 3, 91-129
31. Albers R, Antoine JM, Bourdet-Sicard R, et al. (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94, 452-481
32. Haller D, Blum S, Bode C, et al. (2000) Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: Evidence of NK cells as primary targets. Infect Immun 68, 752-759
33. Lammers KM, Helwig U, Swennen E, et al. (2002) Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 97, 1182-1186
34. Lammers KM, Brigidi P, Vitali B, et al. (2003) Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 38, 165-172
35. Lomax AR & Calder PC (2009) Probiotics, immune function, infection and inflammation: A review of the evidence from studies conducted in humans. Curr Pharm Des 15, 1428-1518
36. Perez-Cano FJ, Dong H & Yaqoob P (2010) In vitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: Two probiotic strains isolated from human breast milk. Immunobiology 215, 996-1004
37. Vissers YM, Snel J, Zuurendonk PF, et al. (2010) Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 59, 60-70
38. Shida K, Nanno M & Nagata S (2011) Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: A possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes 2, 109-114
39. Vissers YM, Snel J, Zuurendonk PF, et al. (2011) Lactobacillus strains differentially modulate cytokine production by hPBMC from pollen-Allergic patients. FEMS Immunol Med Microbiol 61, 28-40
40. Dong H, Rowland I & Yaqoob P (2012) Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr 108, 459-470
41. You J & Yaqoob P (2012) Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486. FEMS Immunol Med Microbiol 66, 353-362
42. Shida K, Suzuki T, Kiyoshima-Shibata J, et al. (2006) Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol 13, 997-1003
43. Lomax AR & Calder PC (2009) Probiotics, immune function, infection and inflammation: A review of the evidence from studies conducted in humans. Curr Pharm Des 15, 1428-1518
44. Ohashi Y, Nakai S, Tsukamoto T, et al. (2002) Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 68, 273-280
45. Morimoto K, Takeshita T, Nanno M, et al. (2005) Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers. Prev Med 40, 589-594
46. Dong H, Rowland I, Thomas LV, et al. (2013) Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. Eur J Nutr (In the Press
47. Shida K & Nanno M (2008) Probiotics and immunology: Separating the wheat from the chaff. Trends Immunol 29, 565-573
48. Yasui H, Kiyoshima J & Hori T (2004) Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol 11, 675-679
49. Kechaou N, Chain F, Gratadoux JJ, et al. (2013) Identification of one novel candidate probiotic Lactobacillus plantarum strain active against influenza virus infection in mice by a large-scale screening. Appl Environ Microbiol 79, 1491-1499
50. Candy DCA, Heath SJ, Lewis JDN, et al. (2008) Probiotics for the young and not so young. Int. J Dairy Technol 61, 215-221
51. Sharma R, Kapila R & Kapila S (2013) Probiotics as antiimmunosenescence agents. Food Rev Int. 29, 201-216
52. Moro-Garcia MA, Alonso-Arias R, Baltadjieva M, et al. (2012) Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects. Age (Dordr) 35, 1311-1326
53. You J, Dong H, Mann ER, et al. (2013) Ageing impairs the T cell response to dendritic cells. Immunobiology (In the Press
54. Dominguez-Bello MG, Blaser MJ, Ley RE, et al. (2011) Development of the human gastrointestinal microbiota and insights from high-Throughput sequencing. Gastroenterology 140, 1713-1719
55. Silvi S, Verdenelli MC, Orpianesi C, et al. (2003) EU project crownalife: Functional foods, gut microflora and healthy ageing. Isolation and identification of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J Food Eng 56, 195-200
56. Likotrafiti E, Manderson KS, Fava F, et al. (2004) Molecular identification and anti-pathogenic activities of putative probiotic bacteria isolated from faeces of healthy elderly individuals. Microb Ecol Health Dis 16, 105-112
57. Pang IK & Iwasaki A (2011) Inflammasomes as mediators of immunity against influenza virus. Trends Immunol 32, 34-41
58. Mazmanian SK, Liu CH, Tzianabos AO, et al. (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118
59. Pang IK & Iwasaki A (2012) Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev 245, 209-226
60. Mortaz E, Adcock IM, Folkerts G, et al. (2013) Probiotics in the management of lung diseases. Mediators Inflamm 2013, 751068
61. Hori T, Kiyoshima J, Shida K, et al. (2002) Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin Diagn Lab Immunol 9, 105-108
62. Harata G, He F, Hiruta N, et al. (2010) Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol 50, 597-602
63. Izumo T, Maekawa T, Ida M, et al. (2010) Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. Int Immunopharmacol 10, 1101-1106
64. Kawase M, He F, Kubota A, et al. (2010) Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection. Lett Appl Microbiol 51, 6-10
65. Salva S, Villena J & Alvarez S (2010) Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: Impact on intestinal and respiratory infections. Int J Food Microbiol 141, 82-89
66. Maruo T, Gotoh Y, Nishimura H, et al. (2012) Oral administration of milk fermented with Lactococcus lactis subsp. cremoris FC protects mice against influenza virus infection. Lett Appl Microbiol 55, 135-140
67. Hatakka K, Savilahti E, Ponka A, et al. (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. BMJ 322, 1327
68. de Vrese M, Winkler P, Rautenberg P, et al. (2006) Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24, 6670-6674
69. Guillemard E, Tondu F, Lacoin F, et al. (2010) Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 103, 58-68
70. Hao Q, Lu Z, Dong BR, et al. (2011) Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 9, CD006895
71. MacDonald TT & Bell I (2010) Probiotics and the immune response to vaccines. Proc Nutr Soc 69, 442-446
72. Olivares M, Diaz-Ropero MP, Sierra S, et al. (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23, 254-260
73. French PW & Penny R (2009) Use of probiotic bacteria as an adjuvant for an influenza vaccine. Int. J Probiotics Prebiotics 4, 175-180
74. Davidson LE, Fiorino AM, Snydman DR, et al. (2011) Lactobacillus GG as an immune adjuvant for live-Attenuated influenza vaccine in healthy adults: A randomized double-blind placebo-controlled trial. Eur J Clin Nutr 65, 501-507
75. Rizzardini G, Eskesen D, Calder PC, et al. (2012) Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12(R) and Lactobacillus paracasei ssp. paracasei, L. casei 431(R) in an influenza vaccination model: A randomised, doubleblind, placebo-controlled study. Br J Nutr 107, 876-884
76. Bunout D, Barrera G, Hirsch S, et al. (2004) Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN J Parenter Enteral Nutr 28, 348-354
77. Boge T, Remigy M, Vaudaine S, et al. (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27, 5677-5684
78. Bosch M, Mendez M, Perez M, et al. (2012) Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutr Hosp 27, 504-509
79. Van Puyenbroeck K, Hens N, Coenen S, et al. (2012) Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: A randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents. Am J Clin Nutr 95, 1165-1171
80. Namba K, Hatano M, Yaeshima T, et al. (2010) Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Biosci Biotechnol Biochem 74, 939-945
81. Kau AL, Ahern PP, Griffin NW, et al. (2011) Human nutrition, the gut microbiome and the immune system. Nature 474, 327-336